Evaluating structural connectivity disruption after stroke: individual tractography or the use of a model-based approach?

评估中风后结构连接性紊乱:个体纤维束追踪还是基于模型的方法?

阅读:1

Abstract

BACKGROUND: Ischemic stroke disrupts structural connectivity between grey matter regions, influencing functional outcomes. Diffusion MRI-based tractography allows assessment of white matter damage and may guide rehabilitation. It remains unclear how structural connectivity disruption (SCD) estimated from individual tractography compares with model-based estimates using normative tractograms. METHODS: Diffusion MRI data were analyzed from 23 individuals with subacute ischemic stroke and 60 healthy adults from two age-specific cohorts (Human Connectome Project/HCP, Alzheimer's Disease Neuroimaging Initiative/ADNI3). In Experiment 1, SCD estimates from individual tractography were compared to scores from the model-based Network Modification (NeMo) tool in the stroke cohort. In Experiment 2, synthetic middle cerebral artery lesions were applied to healthy adults' diffusion data to compare SCD estimates from tractography on synthetically lesioned versus complete data, to SCD estimates from the model-based NeMo tool. Rank-based linear mixed-effects models compared differences across approaches, cohorts, and 13 regions of interest (ROIs). RESULTS: In stroke, SCD scores from individual tractography and NeMo were strongly correlated (R(2) ≥ 0.81), with largest differences in the inferior parietal gyrus (median [IQR]: -4.2% [-9.2-1.4]). In healthy controls, NeMo underestimated SCD relative to individual tractography, with larger median SCD differences across ROIs in older (11.8% [7.7-13.3]) than younger adults (-6.7% [-9.3--1.9]). Cohort and ROI explained 47-69% of variance in SCD difference across approaches. CONCLUSION: Both individual tractography and the model-based framework capture regional SCD patterns, with larger differences in older adults. The model-based framework is efficient for large-scale studies, while individual tractography may better capture patient- and age-specific SCD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。